166 related articles for article (PubMed ID: 29414650)
1. Role of Malt1 protease activity in pathogenesis of inflammatory disorders mediated by FcγR signaling.
Nakamura Y; Yokoyama K; Igaki K; Tsuchimori N
Int Immunopharmacol; 2018 Mar; 56():193-196. PubMed ID: 29414650
[TBL] [Abstract][Full Text] [Related]
2. Requirement of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor-Induced Arthritis, but Not Fcγ Receptor-Mediated Platelet Elimination, in Mice.
Martin K; Touil R; Cvijetic G; Israel L; Kolb Y; Sarret S; Valeaux S; Degl'Innocenti E; Le Meur T; Caesar N; Bardet M; Beerli C; Zerwes HG; Kovarik J; Beltz K; Schlapbach A; Quancard J; Régnier CH; Bigaud M; Junt T; Wieczorek G; Isnardi I; Littlewood-Evans A; Bornancin F; Calzascia T
Arthritis Rheumatol; 2020 Jun; 72(6):919-930. PubMed ID: 31943941
[TBL] [Abstract][Full Text] [Related]
3. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
Front Immunol; 2019; 10():1898. PubMed ID: 31474984
[TBL] [Abstract][Full Text] [Related]
4. MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial Cells.
Alfano DN; Klei LR; Klei HB; Trotta M; Gough PJ; Foley KP; Bertin J; Sumpter TL; Lucas PC; McAllister-Lucas LM
J Immunol; 2020 May; 204(9):2337-2348. PubMed ID: 32213560
[TBL] [Abstract][Full Text] [Related]
5. MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.
Yu JW; Hoffman S; Beal AM; Dykon A; Ringenberg MA; Hughes AC; Dare L; Anderson AD; Finger J; Kasparcova V; Rickard D; Berger SB; Ramanjulu J; Emery JG; Gough PJ; Bertin J; Foley KP
PLoS One; 2015; 10(5):e0127083. PubMed ID: 25965667
[TBL] [Abstract][Full Text] [Related]
6. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
[TBL] [Abstract][Full Text] [Related]
7. MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain.
Kip E; Staal J; Verstrepen L; Tima HG; Terryn S; Romano M; Lemeire K; Suin V; Hamouda A; Kalai M; Beyaert R; Van Gucht S
J Virol; 2018 Apr; 92(8):. PubMed ID: 29367251
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
Bornancin F; Renner F; Touil R; Sic H; Kolb Y; Touil-Allaoui I; Rush JS; Smith PA; Bigaud M; Junker-Walker U; Burkhart C; Dawson J; Niwa S; Katopodis A; Nuesslein-Hildesheim B; Weckbecker G; Zenke G; Kinzel B; Traggiai E; Brenner D; Brüstle A; St Paul M; Zamurovic N; McCoy KD; Rolink A; Régnier CH; Mak TW; Ohashi PS; Patel DD; Calzascia T
J Immunol; 2015 Apr; 194(8):3723-34. PubMed ID: 25762782
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
Front Immunol; 2020; 11():576651. PubMed ID: 33042160
[TBL] [Abstract][Full Text] [Related]
10. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis.
Gilis E; Gaublomme D; Staal J; Venken K; Dhaenens M; Lambrecht S; Coudenys J; Decruy T; Schryvers N; Driege Y; Dumas E; Demeyer A; De Muynck A; van Hengel J; Van Hoorebeke L; Deforce D; Beyaert R; Elewaut D
Arthritis Rheumatol; 2019 Dec; 71(12):2005-2015. PubMed ID: 31259485
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition.
Norris PAA; Kaur G; Khan R; Zhu G; Ni H; Lazarus AH
Blood; 2021 Apr; 137(15):2114-2124. PubMed ID: 33662988
[TBL] [Abstract][Full Text] [Related]
13. Malt1 inactivation attenuates experimental colitis through the regulation of Th17 and Th1/17 cells.
Nakamura Y; Igaki K; Komoike Y; Yokoyama K; Tsuchimori N
Inflamm Res; 2019 Mar; 68(3):223-230. PubMed ID: 30564895
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.
Kip E; Staal J; Tima HG; Verstrepen L; Romano M; Lemeire K; Suin V; Hamouda A; Baens M; Libert C; Kalai M; Van Gucht S; Beyaert R
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158289
[TBL] [Abstract][Full Text] [Related]
15. Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.
Nishimoto T; Okazaki Y; Numajiri M; Kuwana M
Int J Hematol; 2017 May; 105(5):598-605. PubMed ID: 28028748
[TBL] [Abstract][Full Text] [Related]
16. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
17. MALT1 substrate cleavage: what is it good for?
Moud BN; Ober F; O'Neill TJ; Krappmann D
Front Immunol; 2024; 15():1412347. PubMed ID: 38863711
[TBL] [Abstract][Full Text] [Related]
18. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
20. MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
Minderman M; Lantermans HC; Grüneberg LJ; Cillessen SAGM; Bende RJ; van Noesel CJM; Kersten MJ; Pals ST; Spaargaren M
Blood Cancer J; 2023 Mar; 13(1):37. PubMed ID: 36922488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
